TG THERAPEUTICS, INC. Quarterly Operating Margin in % from Q4 2018 to Q4 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Tg Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2018 to Q4 2022.
  • Tg Therapeutics, Inc. Operating Margin for the quarter ending December 31, 2022 was -6.92K %, a 34.3% decline year-over-year.
  • Tg Therapeutics, Inc. annual Operating Margin for 2022 was -6.92K %, a 34.3% decline from 2021.
  • Tg Therapeutics, Inc. annual Operating Margin for 2021 was -5.15K %, a 97.1% increase from 2020.
  • Tg Therapeutics, Inc. annual Operating Margin for 2020 was -180K %, a 61.8% decline from 2019.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 -6.92K -1.77K -34.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -4.65K +3.03K +39.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -4.08K +9.97K +71% Apr 1, 2022 Jun 30, 2022
Q1 2022 -4.08K +30.4K +88.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -5.15K +175K +97.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -7.69K +140K +94.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -14.1K +117K +89.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -34.5K +87K +71.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -180K -68.8K -61.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -148K +32.3K +17.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -132K +31.2K +19.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -121K -11.2K -10.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 -111K +3.52K +3.07% Oct 1, 2019 Dec 31, 2019
Q3 2019 -180K Jul 1, 2019 Sep 30, 2019
Q2 2019 -163K Apr 1, 2019 Jun 30, 2019
Q1 2019 -110K Jan 1, 2019 Mar 31, 2019
Q4 2018 -115K Oct 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.